Abstract
Incidence and prevalence of Mycobacterium fortuitum infection vary greatly by location and death is very rare except in disseminated disease in immunocompromised individuals. We present what we believe is the first case of bone marrow infection with Mycobacterium fortuitum in an HIV negative patient. Bone marrow examination revealed presence of numerous acid fast bacilli which were confirmed as Mycobacterium fortuitum on culture and by molecular analysis. Patient was managed successfully with amikacin and ciprofloxacin.
MeSH terms
-
Amikacin / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Antibiotics, Antitubercular / therapeutic use
-
Bone Marrow / microbiology*
-
Bone Marrow / pathology
-
Bone Marrow Diseases / complications*
-
Bone Marrow Diseases / drug therapy
-
Bone Marrow Diseases / microbiology
-
Ciprofloxacin / therapeutic use
-
Diabetes Mellitus, Type 2 / complications*
-
Humans
-
Isoniazid / therapeutic use
-
Male
-
Middle Aged
-
Mycobacterium Infections, Nontuberculous / complications*
-
Mycobacterium Infections, Nontuberculous / drug therapy
-
Mycobacterium fortuitum / isolation & purification*
-
Rifampin / therapeutic use
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Antibiotics, Antitubercular
-
Ciprofloxacin
-
Amikacin
-
Isoniazid
-
Rifampin